Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future

Jung Hwan Yu, Han Ah Lee, Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S136-S149. Published online December 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0436

View: 4218 Download: 222 Web of Science: 17 Crossref: 17

The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection

Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee

Clin Mol Hepatol. 2022;28(3):351-361. Published online November 26, 2021

DOI: https://doi.org/10.3350/cmh.2021.0281

View: 5295 Download: 257 Web of Science: 15 Crossref: 15

Original Article

Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma

Jungnam Lee, Young-Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Young Ju Suh, Yujin Jeong, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim

Clin Mol Hepatol. 2022;28(2):207-218. Published online November 24, 2021

DOI: https://doi.org/10.3350/cmh.2021.0294

View: 5500 Download: 213 Web of Science: 25 Crossref: 25

Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding

Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong

Clin Mol Hepatol. 2020;26(4):540-553. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0034

View: 6830 Download: 193 Web of Science: 23 Crossref: 23

Letter to the Editor

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

Jung Hwan Yu

Clin Mol Hepatol. 2020;26(2):240-241. Published online March 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0048

View: 4125 Download: 47 Web of Science: 1 Crossref: 1

Editorial

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

Jung Hwan Yu, Jin-Woo Lee

Clin Mol Hepatol. 2019;25(3):280-282. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0104

View: 5660 Download: 126 Web of Science: 1 Crossref: 1

Original Article

Risk Assessment of Hepatitis B virus-related Hepatocellular Carcinoma Development Using Transient Elastography: Systematic Review and Meta-analysis

Young-Joo Jin, Hee Yeon Kim, Miyoung Choi, Seung Up Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun

Received March 4, 2024 Accepted July 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0163 [Accepted]

View: 130 Download: 17

Transient elastography for significant fibrosis in treatment-naïve CHB patients: A systematic review and meta-analysis

Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi

Received May 18, 2024 Accepted July 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0371 [Accepted]

View: 138 Download: 15

Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: A systematic review and meta-analysis

Ji Won Han, Hee Yeon Kim, Jung Hwan Yu, Mi Na Kim, Young Eun Chon, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Han Ah Lee, Dae Won Jun

Received May 4, 2024 Accepted July 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0330 [Accepted]

View: 52 Download: 5

1 |

Viewed By 5659	MAFLD: How is it different from NAFLD?
Viewed By 5578	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5384	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5331	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4984	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 119	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 91	MAFLD: How is it different from NAFLD?
Cited By 82	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search